Cargando…

Biomarkers of Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) is a chronic disease mostly involved with intestine with unknown etiology. Diagnosis, evaluation of severity, and prognosis are still present as challenges for physicians. An ideal biomarker with the characters such as simple, easy to perform, noninvasive or microinv...

Descripción completa

Detalles Bibliográficos
Autores principales: Fengming, Yi, Jianbing, Wu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055235/
https://www.ncbi.nlm.nih.gov/pubmed/24963213
http://dx.doi.org/10.1155/2014/710915
_version_ 1782320625079025664
author Fengming, Yi
Jianbing, Wu
author_facet Fengming, Yi
Jianbing, Wu
author_sort Fengming, Yi
collection PubMed
description Inflammatory bowel disease (IBD) is a chronic disease mostly involved with intestine with unknown etiology. Diagnosis, evaluation of severity, and prognosis are still present as challenges for physicians. An ideal biomarker with the characters such as simple, easy to perform, noninvasive or microinvasive, cheap, rapid, and reproducible is helpful for patients and clinicians. Currently biomarkers applied in clinic include CRP, ESR, pANCA, ASCA, and fecal calprotectin. However, they are far from ideal. Lots of studies are focused on seeking for ideal biomarker for IBD. Herein, the paper reviewed recent researches on biomarkers of IBD to get advances of biomarkers in inflammatory bowel disease.
format Online
Article
Text
id pubmed-4055235
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-40552352014-06-24 Biomarkers of Inflammatory Bowel Disease Fengming, Yi Jianbing, Wu Dis Markers Review Article Inflammatory bowel disease (IBD) is a chronic disease mostly involved with intestine with unknown etiology. Diagnosis, evaluation of severity, and prognosis are still present as challenges for physicians. An ideal biomarker with the characters such as simple, easy to perform, noninvasive or microinvasive, cheap, rapid, and reproducible is helpful for patients and clinicians. Currently biomarkers applied in clinic include CRP, ESR, pANCA, ASCA, and fecal calprotectin. However, they are far from ideal. Lots of studies are focused on seeking for ideal biomarker for IBD. Herein, the paper reviewed recent researches on biomarkers of IBD to get advances of biomarkers in inflammatory bowel disease. Hindawi Publishing Corporation 2014 2014-05-19 /pmc/articles/PMC4055235/ /pubmed/24963213 http://dx.doi.org/10.1155/2014/710915 Text en Copyright © 2014 Y. Fengming and W. Jianbing. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Fengming, Yi
Jianbing, Wu
Biomarkers of Inflammatory Bowel Disease
title Biomarkers of Inflammatory Bowel Disease
title_full Biomarkers of Inflammatory Bowel Disease
title_fullStr Biomarkers of Inflammatory Bowel Disease
title_full_unstemmed Biomarkers of Inflammatory Bowel Disease
title_short Biomarkers of Inflammatory Bowel Disease
title_sort biomarkers of inflammatory bowel disease
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055235/
https://www.ncbi.nlm.nih.gov/pubmed/24963213
http://dx.doi.org/10.1155/2014/710915
work_keys_str_mv AT fengmingyi biomarkersofinflammatoryboweldisease
AT jianbingwu biomarkersofinflammatoryboweldisease